SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2006-11-30
Filing Date Changed: 2006-11-30
Documents: 7
SEC Accession No.
0000078003-06-000319
Filing date: 2006-11-30
Accepted: 2006-11-30 12:48:50
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K k8pfe-20060702.htm 19218 XBRL PFIZER 8-K
2 EX-100.INS pfe-20060702.xml 46850 XBRL INSTANCE DOCUMENT
3 EX-100.SCH pfe-20060702.xsd 9334 XBRL EXTENSION TAXONOMY
4 EX-100.SCH.1 pfe-ssu_xbrl.xsd 610 XBRL SCHEMA SUPPLEMENT DOCUMENT
5 EX-100.CAL pfe-20060702_cal.xml 54073 XBRL CALCULATION LINKBASE
6 EX-100.LAB pfe-20060702_lab.xml 75506 XBRL LABEL LINKBASE
7 EX-100.PRE pfe-20060702_pre.xml 40742 XBRL PRESENTATION LINKBASE
0000078003-06-000319.txt 248772 Complete submission text file

Filer Information:

PFIZER INC (Filer) (0000078003)
IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 061247559
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
235 E 42ND ST
NEW YORK NY 10017
2125732323
 Mailing Address
235 E 42ND ST
NEW YORK NY 10017